Publication for HNRNPL and SFPQ

Species	Symbol	Function*	Entrez Gene ID*	Other ID	Gene coexpression	CoexViewer
hsa	HNRNPL	heterogeneous nuclear ribonucleoprotein L	3191			[link]
hsa	SFPQ	splicing factor proline and glutamine rich	6421

Pubmed ID	Priority	Text
27658966	0.98	PSF or anti- hnRNP L or anti-NCL or anti-HSPA1A or anti-PABPC1 antibodies followed by WB analysis using specific antibodies.
	0.90	hnRNP L, HSPA1A, PABPC1, PSF and NONO) followed by WB analysis with anti-ADAR1 antibody.
	0.69	hnRNP L, NONO, PSF and NCL the endogenous ADAR1 was Co-IP.
	0.67	hnRNP L, NONO, PSF, PABPC1, HSPA1A and NCL) and by treatment with an RNase mix it was determined that most of these associations are RNA-dependent.
28934469	0.97	hnRNP L and hnRNP A1 (Figure 4B and C), and additional splicing inhibitory factors such as PTB and PSF (Figure 4B).
	0.92	hnRNP L, hnRNP A1, U2AF65 and U2AF35, such as SRSF1, PSF, hnRNP A2B1, Sam68, Tra2b, hnRNP LL and hnRNP C1 (Figure 4B).
	0.90	hnRNP L, hnRNP A1, PSF and PTB could interfere negatively with the recognition of SA5639 by interacting or interfering with U2AF65/35.
	0.56	hnRNP L or U1-70K, followed by Western blotting with antibodies to hnRNP L, PSF, Sam68 or hnRNP C1.
30216987	0.97	SFPQ, HNRPK, HNRPR, ILF3, HNRPL; B:EGR1, MYF5, TOPRS, NEIL2, TNR4, MYOD1, p53, MYF6, MYOG, IGF2, TERT, NEIL1, ACD, RECQ4, TINF2; C:NUCL, NPM, TOP1, EBNA1BP2, POTE1, CAMP, NDKB, DHX36, SF3B3, ILF2, NOA1, DHX30, DHX15, DPOE1, ERCC2, EFHD2, ERCC3, TERF1, SAFB1, SAFB2, DNM3B, FMR1, U2AF2, TERF2, DSRAD, SPAST, DNM3A, TE2IP, DNMT1, NEIL3, ADA10, IF16, PARP1, DDX21, POLH, BRCA1, NF2L2, ATRX, BLM, FANCJ, RFA2, RFA1, ELAV1) of proteins supported by approximately unbiased values (AU equal to or greater than 95 is considered to be statistically significant).
31671760	0.97	SFPQ, PTB, hnRNP L, hnRNP Q, NCL, RPL26, and Ku), there are also proteins RNPC1, Pdcd4, DAP5, TCP80, and RHA.
20122404	0.96	hnRNP L. One explanation for these results is that the addition of PSF to the ARS complex could directly inhibit the enhancement activity of hnRNP L, perhaps by blocking the ability of hnRNP L to recruit the U2 snRNP.
	0.84	PSF participates with hnRNP L in the stimulation-induced silencing of CD45 exon 5, as it does for exon 4, whereas hnRNP LL has little or no effect on the regulation of CD45 exon 5.
29180447	0.96	SFPQ), the heterogeneous nuclear ribonucleoprotein L (hnRNP L), and the non-POU domain-containing octamer-binding protein (NONO), selectively bound to the variant intron 5 versus wildtype intron 5 (p < 0.05) encompassing SNPd (Fig. 2B).
	0.96	SFPQ, hnRNP L, and NONO selectively bound to the mutated DR3 intron 5 pre-mRNA versus wildtype intron 5.
20932480	0.96	PSF, P-Thr or hnRNP L as loading control.
23550649	0.95	hnRNP L and PSF mediate exon 5 repression through binding to the ARS, the ESE is also important for regulation and specifically for promoting the relatively high level of inclusion of this exon.
	0.93	hnRNP L in the signal-responsive repression of CD45 is PTB-associated splicing factor (PSF).
	0.77	PSF is required for maximal activation-induced repression of the CD45 variable exons as indicated by the fact that mutation of the PSF-recognition element increases CD45 exon inclusion in activated cells without affecting binding of hnRNP L or LL.
22207834	0.95	hnRNP L and PSF is indeed CA-rich, similar to the CaRRE elements (Melton et al.,).
23737958	0.93	SFPQ (PSF), PTEN, PUR-alpha, TAF1, TAF15, and hnRNP_L (the detailed information of these hub proteins is shown in Table S2).
25599992	0.93	hnRNP-L, PSF, hnRNPA1, hnRNPA2B1, hnRNPC and MRG15 (Patton et al,; Hahm et al,; Luco et al,; King et al,), although we did identify the helicase DDX3X (King et al,).
31268164	0.92	HNRNPL, SRSF9, SRSF2, DAZAP1 and SFPQ (Fig. 9).
19854948	0.89	hnRNPL, PSF and other factors.
18669861	0.87	hnRNPL, PSF (poly-pyrimidine tract binding protein-associated splicing factor), and hnRNPE2, have been shown to bind CD45 transcripts.
25112293	0.74	PTB-associated splicing factor (PSF) and hnRNP L) and/ or transcriptional induction of a cofactor during T cell signalling.